Roche Holding AG (RHHBY)
53.83
+0.74
(+1.39%)
USD |
OTCM |
Sep 02, 16:00
Roche Research and Development Expense (TTM) : 15.04B for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.04B |
| December 31, 2025 | 14.76B |
| June 30, 2025 | 14.81B |
| December 31, 2024 | 14.81B |
| June 30, 2024 | 14.88B |
| December 31, 2023 | 14.74B |
| June 30, 2023 | 14.59B |
| December 31, 2022 | 14.12B |
| June 30, 2022 | 14.06B |
| December 31, 2021 | 14.99B |
| June 30, 2021 | 14.35B |
| December 31, 2020 | 12.97B |
| June 30, 2020 | 12.20B |
| December 31, 2019 | 11.77B |
| June 30, 2019 | 11.35B |
| December 31, 2018 | 11.29B |
| June 30, 2018 | 11.00B |
| December 31, 2017 | 10.56B |
| June 30, 2017 | 10.25B |
| December 31, 2016 | 10.06B |
| June 30, 2016 | 9.961B |
| December 31, 2015 | 9.687B |
| June 30, 2015 | 9.608B |
| December 31, 2014 | 9.746B |
| June 30, 2014 | 9.698B |
| Date | Value |
|---|---|
| December 31, 2013 | 9.386B |
| June 30, 2013 | 9.750B |
| December 31, 2012 | 9.534B |
| June 30, 2012 | 9.051B |
| December 31, 2011 | 9.125B |
| June 30, 2011 | 9.820B |
| December 31, 2010 | 9.668B |
| June 30, 2010 | 8.939B |
| December 31, 2009 | 8.788B |
| June 30, 2009 | 8.145B |
| December 31, 2008 | 8.033B |
| June 30, 2008 | 7.835B |
| December 31, 2007 | 6.932B |
| June 30, 2007 | |
| December 31, 2006 | |
| June 30, 2006 | |
| December 31, 2005 | |
| June 30, 2005 | |
| December 31, 2004 | |
| June 30, 2004 | |
| December 31, 2003 | |
| June 30, 2003 | |
| December 31, 2002 | |
| June 30, 2002 | |
| December 31, 2001 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Novartis AG | 11.26B |
| Eli Lilly & Co. | 14.60B |
| Merck & Co., Inc. | 27.26B |
| AstraZeneca PLC | 14.21B |
| Pfizer Inc. | 10.82B |